Planned Transition to Sirolimus-Based Therapy Versus Continued Tacrolimus-Based Therapy in Renal Allograft Recipients.

Trial Profile

Planned Transition to Sirolimus-Based Therapy Versus Continued Tacrolimus-Based Therapy in Renal Allograft Recipients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2014

At a glance

  • Drugs Sirolimus (Primary) ; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 08 Nov 2013 Top-line results reported in a Pfizer media release.
    • 08 Nov 2013 Status changed from recruiting to completed, as reported by a Pfizer media release.
    • 08 Nov 2013 Primary endpoint 'significant difference in percentage of patients with an improvement in glomerular filtration rate over 24 months' has not been met, as reported by a Pfizer media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top